Aug 18, 2025 9:00am EDT Capricor Therapeutics Announces First Subjects Dosed in Phase 1 Clinical Trial of Novel Exosome-Based Vaccine
Aug 11, 2025 4:05pm EDT Capricor Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Aug 11, 2025 4:30 pm EDT Capricor Therapeutics Second Quarter 2025 Financial Results and Corporate Update Conference Call